Detection of vimentin methylation in the serum of patients with gastric cancer

Anticancer Research

Volumn 32, Issue 3, 2012, Pages 791-794

  Shirahata, Atsushi ^a   Sakuraba, Kazuma ^a   Kitamura, Youhei ^a   Yokomizo, Kazuaki ^a   Gotou, Tetsurou ^a   Saitou, Mitsuo ^a   Kigawa, Gaku ^a   Nemoto, Hiroshi ^a   Sanada, Yutaka ^a   Hibi, Kenji ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Gastric carcinoma; Quantitative methylation specific PCR; VIM

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GENOMIC DNA; VIMENTIN;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS; DNA METHYLATION; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STOMACH CANCER; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; HUMANS; MALE; METHYLATION; MIDDLE AGED; POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; VIMENTIN;

EID: 84858780448     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Leon SA, Shapiro B, Sklaroff DM and Yaros MJ: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650, 1977. (Pubitemid 8051621)
2. Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C and Beljanski M: Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46: 318-322, 1989. (Pubitemid 19216753)
3. Hibi K, Robinson CR, Booker S, Wu L, Hamilton SR, Sidransky D and Jen J: Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 58: 1405-1407, 1998. (Pubitemid 28193600)
4. Mulcahy HE, Lyautey J, Lederrey C, Qi Chen X, Anker P, Alstead EM, Ballinger A, Farthing MJ and Stroun M: A prospective study of KRAS mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 4: 271-275, 1998. (Pubitemid 28122737)
5. Ito S, Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S and Nakao A: Detection of tumor DNA in serum of colorectal cancer patients. Jpn J Cancer Res 93: 1266-1269, 2002. (Pubitemid 36032991)
6. Uemura T, Hibi K, Kaneko T, Takeda S, Inoue S, Okochi, Nagasaka T and Nakao A: Detection of KRAS mutations in the plasma DNA of pancreatic cancer patients. J Gastroenterol 39: 56-60, 2004. (Pubitemid 38208243)
7. Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, Ito K, Akiyama S and Nakao A: Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int J Cancer 94: 429-431, 2001. (Pubitemid 32906076)
8. Okochi O, Hibi K, Uemura T, Inoue S, Takeda S, Kaneko T and Nakao A: Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res 8: 2875-2878, 2002. (Pubitemid 35025733)
9. ink4A alleles in neoplasia. Cancer Res 58: 591-593, 1998.
10. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB and Herman JG: Hypermethylation-associated inactivation of p14 (ARF) is independent of p16 (INK4A) methylation and p53 mutational status. Cancer Res 60: 129-133, 2000. (Pubitemid 30058742)
11. Hibi K, Nakayama H, Kanyama Y, Kodera Y, Ito K, Akiyama S and Nakao A: Methylation pattern of HLTF gene in digestive tract cancers. Int J Cancer 104: 433-436, 2003. (Pubitemid 36323912)
12. Fujitake S, Hibi K, Okochi O, Kodera Y, Ito K, Akiyama S and Nakao A: Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J Gastroenterol 39: 120-124, 2004. (Pubitemid 38325187)
13. Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S and Nakao A: CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer. Br J Cancer 90: 1030-1033, 2004. (Pubitemid 38495824)
14. Nakayama H, Hibi K, Taguchi M, Takase T, Yamazaki T, Kasai Y, Ito K, Akiyama S and Nakao A: Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. Cancer Lett 188: 115-119, 2002. (Pubitemid 35292337)
15. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S and Shuber A: Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 5: 111-117, 2007. (Pubitemid 46096834)
16. Zou H, Harrington JJ, Shire AM, Rego RL, Wang L, Campbell ME, Oberg AL and Ahlquist DA: Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev 16: 2685-2696, 2007.
17. Brenner DE and Rennert G: Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible? J Natl Cancer Inst 97: 1107-1109, 2005. (Pubitemid 41511203)
18. Zou H, Harrington J, Rego RL and Ahlquist DA: A novel method to capture methylated human DNA from stool: Implications for colorectal cancer screening. Clin Chem 53: 1646-1651, 2007. (Pubitemid 47340061)
19. Kitamura Y, Shirahata A, Sakata M, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and Hibi K: Frequent methylation of vimentin in well-differentiated gastric carcinoma. Anticancer Res 29: 2227-2229, 2009.
20. International Union Against Cancer: TNM Classification of Malignant Tumors (7th edition).This Japanese edition is based on the original edition in English (L.H. Sobin, M.K. Gospodarowicz and Ch.Wittekind (eds.). New York, Wiley, pp. 94-99, 2010.
21. Fuchs CS and Mayer RJ: Gastric carcinoma. N Engl J Med 333: 32-41, 1995.
22. Hibi K, Taguchi M, Nakayama H, Takase T, Kasai Y, Ito K, Akiyama S and Nakao A: Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 7: 3135-3138, 2001 (Pubitemid 32963835)
23. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB and Herman JG: Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59: 67-70, 1999. (Pubitemid 29062958)
24. Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM and Johnson PJ: Detection of aberrant pl6 methylation in the plasma and serum of liver cancer patients. Cancer Res 59: 71-73, 1999. (Pubitemid 29062959)
25. Nakayama H, Hibi K, Takase T, Yamazaki T, Kasai Y, Ito K, Akiyama S and Nakao A: Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients. Int J Cancer 105: 491-493, 2003. (Pubitemid 36578552)
26. Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, Jen J, Herman JG and Sidransky D: Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60: 892-895, 2000. (Pubitemid 30129522)
27. Li M, Chen WD, Papadopoulos N, Goodman S, Bjerregaarg NC, Laurberg S, Levin B, Juhl H, Arber N, Moinova H, Durkee K, Schmidt K, He Y, Diehl F, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW, Markowitz SD and Vogelstein B: Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 27: 858-863, 2009.
28. Shirahata A, Sakuraba K, Goto T, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and Hibi K: Detection of vimentin (VIM) methylation in the serum of colorectal cancer patients. Anticancer Res 30: 5015-5018, 2010.
29. Vogelstein B and Kinzler KW: Digital PCR. Proc Natl Acad Sci USA 96: 9236-9341, 1999.